Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients

Lan Gong, Xinghuai Sun, Jia Qu et al.|Clinical Therapeutics|2012

Cited by 24